Medication-Assisted Treatment

NorthShore Health Centers, in collaboration with Frontline Foundations, now provides substance abuse counseling, including medication-assisted treatment (MAT) with Vivitrol. Administered by our dedicated NorthShore providers, Vivitrol, an opioid antagonist, plays a crucial role in blocking the effects of drugs, reducing cravings, and supporting individuals in their journey to recovery. Our program emphasizes both medical support and counseling services to ensure comprehensive care for those seeking assistance in overcoming substance abuse challenges.

iStock-1143276135-980x652

Medication-Assisted Treatment

NorthShore Health Centers, in collaboration with Frontline Foundations, now provides substance abuse counseling, including medication-assisted treatment (MAT) with Vivitrol. Administered by our dedicated NorthShore providers, Vivitrol, an opioid antagonist, plays a crucial role in blocking the effects of drugs, reducing cravings, and supporting individuals in their journey to recovery. Our program emphasizes both medical support and counseling services to ensure comprehensive care for those seeking assistance in overcoming substance abuse challenges.

iStock-1143276135-980x652

Frontline foundation substance abuse counseling

NorthShore Health Centers now offers substance abuse counseling through Frontline Foundations. However, in some cases medication-assisted treatment (MAT) might be needed in addition to counseling to help address the physical changes that substance abuse can have on the brain.

NorthShore Health Centers has collaborated with Frontline Foundations in an effort to provide access to Vivitrol services to patients in need within the community. A select number of NorthShore providers oversee the medical services within the program and give the injections to the patients monthly. Patients in the program are required to participate in counseling services provided by Frontline Foundations.

Vivitrol is an opioid antagonist that blocks the effects of the drugs. It contains naltrexone, an opioid antagonist that is non-pleasure-producing. This means that the patient will not experience a high and the patient will not experience withdrawal symptoms if they stop treatment.

During a six-month-long study on the effect of Vivitrol use for opioid abuse, those who received the drug were 17 times less likely to relapse to physical dependence, had a 55% decline in opioid cravings from baseline, had 90% opioid-free weeks, and stayed in treatment longer than those who received a placebo.

During a six-month-long study on the effect of Vivitrol use for alcohol dependence, those who received the drug reported a 25% greater reduction in days of heavy drinking than those who received the placebo.

Vivitrol is administered every four weeks. If a patient misses their dose of Vivitrol, they should be seen to receive the next dose as soon as they can. A minimum of 7-10 days opioid-free prior to beginning Vivitrol is recommended.

Meet Our Providers

Substance Abuse
Substance Abuse, Behavioral Health
Substance Abuse
Substance Abuse
Substance Abuse